More about

Mash Fibrosis

News
November 11, 2024
1 min watch
Save

VIDEO: Better rates of fibrosis reversal in MASH with Rezdiffra 100 mg, data show

PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine and director of hepatology at Stanford University, discusses data from the ongoing MAESTRO-NASH trial, which were presented at the ACG Annual Scientific Meeting.